Navigation Links
Increased SVR and Decreased Adverse Events Reported in Final Results of Phase 3 Study on Telaprevir
Date:11/1/2010

vents leading to treatment discontinuation occurred in 7 percent of patients in the arm receiving telaprevir combination treatment for 12 weeks, 8 percent in telaprevir for 8 weeks, and 4 percent in the peginterferon alfa-2a and ribavirin arm.

Abstract title:

Telaprevir in Combination with Peginterferon and Ribavirin in Genotype 1 HCV Treatment-Naive Patients: Final Results of Phase 3 ADVANCE Study

About the AASLD

AASLD is the leading medical organization for advancing the science and practice of hepatology. Founded by physicians in 1950, AASLD's vision is to prevent and cure liver diseases. This year's Liver Meeting®, held in Boston, Massachusetts, October 29-November 2, will bring together more than 7,500 researchers from 55 countries.

A pressroom will be available from October 30 at the annual meeting. For copies of abstracts and press releases, or to arrange for pre-conference research interviews contact Gregory Bologna at 703-299-9766. To pre-register, call Ann Haran at 703-299-9766.

Press releases and all abstracts are available online at www.aasld.org.

Quote from Dr. Jacobson: "This phase 3 trial confirms previous findings that telaprevir confers  higher rates of viral cure in patients with the highly prevalent genotype 1 when compared with the current standard of care, with the added advantage of a  shorter total duration of treatment  in the majority of patients.  Although rash and anemia were more common with telaprevir, treatment discontinuation due to side effects was very infrequent and side effects attributable to the drug are reversible.  This study, along with others on protease inhibitors at this year's meeting, heralds an  exciting new era in HCV therapy in which increasing numbers of patients will be cured and spared the life-threatening risks of advanced liver disease."Media Contact: Gregory Bologna703/299-9766gbologna@aasld.o
'/>"/>

SOURCE American Association for the Study of Liver Diseases (AASLD)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline
2. FDA: Possible Increased Risk of Thigh Bone Fracture With Bisphosphonates
3. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
4. Alere Inc. Announces Pricing of Senior Subordinated Notes Offering; Offering Size Increased to $400.0 Million
5. Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India
6. Through 2019, Increased Generic Erosion of Key Agents Such as Lamictal and Depakote/Depakote ER Will Cause a Precipitous $2.3 Billion Decline in the Bipolar Disorder Drug Market
7. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
8. Medical Affairs Budget & Staffing Remain Top Challenges Despite Increased Funding
9. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
10. APC Group, Inc. Reports Fiscal Year End Sales Revenues Increased 30% for 2009
11. New Study Links dLife to Increased Rx Drug Usage Among Diabetes Consumers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 ... plc (NASDAQ: ENDP ) (TSX: ENL), and ... announced today that they have submitted a New Drug ... U.S. Food and Drug Administration (FDA).  Buprenorphine HCl Buccal ... severe enough to require daily, around-the-clock, long-term opioid treatment ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... the "US Self-monitoring Blood Glucose Market" report ... This market insight focuses on the ... the United States . Reimbursement analysis and ... product analyses for more than 73 SMBG meters have ...
(Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), today provided ... merger with Carrollton, Texas-based FirstFitness Nutrition Inc., a leading ... products.  On November 9th, 2011, Medical Alarm Concepts announced ... its plan to merge the financials and operations of ...
... human papillomavirus vaccine that is now recommended for male ... autoimmune conditions such as lupus, rheumatoid arthritis, type 1 ... according to a new study in the Journal ... used electronic health records to conduct an observational safety ...
Cached Medicine Technology:MDHI Provides Update on FirstFitness Merger - Operation Expected to Produce 2012 Revenues in Excess of $12 Mil - Warrants of 15.5 Mil Cancelled 2MDHI Provides Update on FirstFitness Merger - Operation Expected to Produce 2012 Revenues in Excess of $12 Mil - Warrants of 15.5 Mil Cancelled 3MDHI Provides Update on FirstFitness Merger - Operation Expected to Produce 2012 Revenues in Excess of $12 Mil - Warrants of 15.5 Mil Cancelled 4MDHI Provides Update on FirstFitness Merger - Operation Expected to Produce 2012 Revenues in Excess of $12 Mil - Warrants of 15.5 Mil Cancelled 5Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination 2Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination 3Kaiser Permanente Study Finds Gardasil Does Not Trigger Lupus, Rheumatoid Arthritis or Type 1 Diabetes After Vaccination 4
(Date:12/24/2014)... December 24, 2014 For nearly 20 ... housewarmings, new babies, graces, and all of life's rites ... and author, Nancy Tupper Ling, in Toasts: The ... Viva Editions. , Organized by category and containing ... won't appear anywhere else, this timely tome contains sayings ...
(Date:12/24/2014)... As 2014 draws to a close, ... investing time and money into a new or tankless ... specializes in tankless and eco-friendly products or service. Greenstar ... heater in 2015 to research “green” and environmentally friendly ... Home Services specializes in eco-friendly and environmentally conscious ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, ... might hurt your child in the classroom, a new study ... grade lagged behind by eighth grade, said researchers who reviewed ... "The largest effects were found for the kids who ... Purtell, assistant professor of human sciences at Ohio State University. ...
(Date:12/24/2014)... (HealthDay News) -- Long-term fear of terrorists may damage your ... new study from Israel suggests. , , Conducted by researchers ... Israelis. In Israel, the threat of war and terrorism has ... "We wanted to test whether fear of terrorism can ... death," study author Hermona Soreq, a professor of molecular neuroscience, ...
(Date:12/22/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief compliance officer ... Oceanside, Calif. The top executive search firm ... placed more than 900 healthcare executives into organizations. ... Gold Seal-approved, full-service acute-care hospital serving San Diego County’s ...
Breaking Medicine News(10 mins):Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:Can Fast Food Hinder Learning in Kids? 2Health News:Terrorism Fears May Shorten Your Life, Study Finds 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 3
... published in volume 14 issue 6 of World ... presented to Dr Cosimo Sperti of University of ... laparotomy performed in another hospital for an unresectable ... vein. Total pancreatectomy together with resection and reconstruction ...
... Ph.D., MBA, RN is vice president of research,and ... announced it,has appointed Joann Genovich-Richards, Ph.D., MBA, RN, ... research and measurement. The,position will support the development ... analyze existing data from accredited companies and,other sources ...
... March 13 inVentiv Clinical,Solutions, LLC (inVentiv Clinical), ... that they will establish operations in Latin,America, a ... will be,based in Sao Paulo, Brazil, with the ... inVentiv Clinical,s Latin American operations,will be led by ...
... TOC ; TSX: TOC) has been selected by ... care hospitals in high-growth urban and,suburban markets, to complete ... care hospitals., Like other health systems in the ... a limited field of candidates.,Thomson Healthcare, using its Market ...
... Ohio, March 13 Cardinal Health, a,global ... the safety and,productivity of health care, today ... Kaufmann as group president of its Healthcare ... role, Kaufmann, 45, will be responsible for ...
... the Future, JACKSON, Miss., March 13 ... technology partner, announces Christwood Retirement,Community in Covington, ... Study,(OBS) partner site for SamarionSolution(SM), the nursing ... Christwood, which recently celebrated a decade as ...
Cached Medicine News:Health News:URAC Announces New Leadership to Mine Health Care Management Data and Develop Measurement Programs 2Health News:URAC Announces New Leadership to Mine Health Care Management Data and Develop Measurement Programs 3Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 2Health News:inVentiv Clinical Expands Operations to Emerging Latin American Region 3Health News:Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare 2Health News:Thomson Healthcare Undertakes Medical Staff Development Project for IASIS Healthcare 3Health News:Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment 2Health News:Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industry's Only Enterprise Quality Improvement System 2Health News:Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industry's Only Enterprise Quality Improvement System 3
... For use in the percutaneous retrieval of indwelling ... wire guides, and other foreign objects. A ... around the lead body. It is delivered to ... flexible 12 Fr cannula that is placed coaxially ...
... Novalis, BrainLAB's dedicated ... radiosurgery and radiotherapy (SRS/SRT), ... highly precise treatments of ... head & neck tumors, ...
The Radionics XKnife RT2 system provides a precise and versatile stereotactic radiation therapy solution....
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: